Table 3 Predictive factors for major complications at 30 post-operative days.
Univariable analysis | Multivariable analysis | |||||
---|---|---|---|---|---|---|
OR | 95% CI | p value | Adjusted OR | 95% CI | p value | |
Age > 70 years | 1.41 | 0.73–2.70 | 0.303 | |||
Gender (female) | 0.35 | 0.18–0.66 | 0.001 | 0.39 | 0.19–0.79 | 0.009 |
BMI > 25 kg/m2 | 0.97 | 0.52–1.81 | 0.926 | |||
ASA III/IV | 1.85 | 0.96–3.57 | 0.066 | 1.92 | 0.94–3.93 | 0.075 |
WHO performance > 0 | 4.58 | 1.28–16.41 | 0.019 | 5.63 | 1.46–21.71 | 0.012 |
Active smoking | 0.91 | 0.45–1.83 | 0.781 | |||
Diabetes | 0.70 | 0.30–1.64 | 0.41 | |||
Malignant tumor | 1.36 | 0.54–3.44 | 0.521 | |||
Neoadjuvant chemotherapy | 0.75 | 0.21–2.68 | 0.662 | |||
Soft pancreatic texture | 1.55 | 0.79–3.02 | 0.201 | |||
Non-dilated pancreatic main duct | 2.35 | 1.22–4.52 | 0.011 | 2.22 | 1.10–4.50 | 0.026 |
Length surgery > 300 min | 1.14 | 0.60–2.17 | 0.697 | |||
Intraoperative blood loss > 400 ml | 1.21 | 0.64–2.29 | 0.554 | |||
Venous resection | 0.73 | 0.35–1.52 | 0.402 | |||
IV POD 0 ≥ 4400 ml | 1.24 | 0.65–2.37 | 0.506 |